| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +25.71% | +0.44% | +25.28% | +25.28% | — |
| 14d | 1 | +0.00% | +26.67% | +0.73% | +25.94% | +25.94% | — |
| 30d | 1 | +0.00% | +35.24% | +2.34% | +32.90% | +32.90% | — |
| 60d | 1 | +0.00% | +33.33% | +4.44% | +28.90% | +28.90% | — |
| 90d | 1 | +0.00% | +38.09% | +7.45% | +30.64% | +30.64% | — |
| 180d | 1 | +0.00% | +16.19% | +11.37% | +4.83% | +4.83% | — |
| 1y | 1 | +0.00% | +27.62% | +20.91% | +6.71% | +6.71% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PMVP PMV PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 319,270 | — | — | 319,270 | Mar 5, 2026 | Mar 9, 2026 ↗ | View → |
| PMVP PMV PHARMACEUTICALS, INC. | SALE General Counsel & COO | 23,151 | $1.06 | $24.7K | 98,695 | Jul 1, 2025 | Jul 3, 2025 ↗ | View → |